X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Pfizer Fact Sheet, Pfizer Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer Fact Sheet    (PFIZ)

Here is the latest financial fact sheet of Pfizer. For more details, see the Pfizer quarterly results and Pfizer share price and chart. For a sector overview, read our pharmaceuticals sector report.

PFIZER Price History

Price Rs 3,193.1
Mkt Cap Rs m 146,084
Vol '000 0.2
P/E X 34.0
P/CF X 34.3
EPS (TTM) Rs 93.8
% ch % 0.1
No. of shares m 45.75
% ch week % 1.4
% ch 1-mth % 0.9
% ch 12-mth % 24.2
52 week H/L Rs 3,840.0/2,490.0
(As on Jul 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PFIZER Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
PFIZER EQUITY SHARE DATA
High Rs1,7792,3252,7242,0552,365 
Low Rs9851,1751,6111,6511,625 
Sales per share (Unadj.) Rs372.6405.1439.9429.8430.3 
Earnings per share (Unadj.) Rs74.015.366.773.678.7 
Diluted earnings per shareRs48.315.366.773.678.7 
Cash flow per share (Unadj.) Rs76.743.979.387.493.2 
Dividends per share (Unadj.) Rs360.0012.5015.0020.0020.00 
Adj. dividends per shareRs234.8112.5015.0020.0020.00 
Dividend yield (eoy) %26.00.70.71.11.0 
Book value per share (Unadj.) Rs220.6420.0472.9528.7586.5 
Adj. book value per shareRs143.9420.0472.9528.7586.5 
Shares outstanding (eoy) m29.8445.7545.7545.7545.75 
Bonus/Rights/Conversions  -A--- 
Price / Sales ratio x3.74.34.94.34.6 
Avg P/E ratio x18.7114.732.525.225.3 
P/CF ratio (eoy) x18.039.927.321.221.4 
Price / Book Value ratio x6.34.24.63.53.4 
Dividend payout %486.481.922.527.225.4 
Avg Mkt Cap Rs m41,23980,06399,16384,77791,271 
No. of employees `0002.4NA2.92.82.6 
Total wages/salary Rs m1,9182,3642,7733,0393,143 
Avg. sales/employee Rs Th4,600.0NM6,965.56,925.97,484.8 
Avg. wages/employee Rs Th793.4NM960.01,070.41,195.0 
Avg. net profit/employee Rs Th913.8NM1,055.71,186.31,369.1 
PFIZER INCOME DATA
Net Sales Rs m11,11818,53320,12319,66319,685 
Other income Rs m1,0946748701,0121,143 
Total revenues Rs m12,21219,20720,99320,67420,828 
Gross profit Rs m2,3853,8304,3203,4915,003 
Depreciation Rs m801,311579629663 
Interest Rs m485104 
Profit before tax Rs m3,3963,1854,6053,8645,479 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0-1,110991,3040 
Tax Rs m1,1871,3771,6541,8011,878 
Profit after tax Rs m2,2096983,0503,3683,601 
Gross profit margin %21.520.721.517.825.4 
Effective tax rate %35.043.235.946.634.3 
Net profit margin %19.93.815.217.118.3 
PFIZER BALANCE SHEET DATA
Current assets Rs m6,86012,50616,32520,51324,167 
Current liabilities Rs m3,0345,3966,5847,7979,544 
Net working cap to sales %34.438.448.464.774.3 
Current ratio x2.32.32.52.62.5 
Inventory Days Days5076656055 
Debtors Days Days5732262029 
Net fixed assets Rs m2329,9969,6469,1759,514 
Share capital Rs m298458458458458 
"Free" reserves Rs m6,28618,75821,17823,73126,375 
Net worth Rs m6,58419,21521,63524,18926,832 
Long term debt Rs m025252525 
Total assets Rs m9,76725,43428,88132,61036,900 
Interest coverage x944.3414.6886.7403.51,305.5 
Debt to equity ratio x00000 
Sales to assets ratio x1.10.70.70.60.5 
Return on assets %22.72.810.610.49.8 
Return on equity %33.53.614.113.913.4 
Return on capital %51.610.821.721.420.4 
Exports to sales %00.10.100 
Imports to sales %9.423.117.500 
Exports (fob) Rs m591200 
Imports (cif) Rs m1,0504,2743,52600 
Fx inflow Rs m83117526322 
Fx outflow Rs m9,4314,3831404,0671,489 
Net fx Rs m-9,348-4,266-88-4,004-1,466 
PFIZER CASH FLOW
From Operations Rs m 1,325 1,135 3,455 3,288 3,318 
From Investments Rs m 1,027 -888 -7,009 -2,496 -2,383 
From Financial Activity Rs m -13,602 -14 -619 -826 -1,104 
Net Cashflow Rs m -11,251 233 -4,174 -35 -169 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 63.9%
Indian inst/Mut Fund 7.5%
FIIs 4.9%
ADR/GDR 0.0%
Free float 23.7%
Shareholders 85,207
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Pfizer Centre, Patel Estate, S. V. Road, Jogeshwari (W), Mumbai - 400 102
E-MAIL prajeet.nair@pfizer.com WEB www.pfizerindia.com
TELEPHONE (022) 6693 2000 FAX (022) 2678 4569
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR B S R & Co. LLP
CHM: R. A. Shah COMP SEC: Prajeet Nair YEAR OF INC: 1950 BSE CODE: 500680 FV (Rs): 10 DIV YIELD (%): 0.6

Read: PFIZER 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  

Compare PFIZER With:   DISHMAN PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Views on news

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PFIZER

MORE ON PFIZER

PFIZER - STRIDES PHARMA SCIENCE COMPARISON

COMPARE PFIZER WITH

MARKET STATS